A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics Melissa E. Badowski Review Article Open access 05 August 2017 Pages: 441 - 449
sIL-24 peptide, a human interleukin-24 isoform, induces mitochondrial-mediated apoptosis in human cancer cells Samira ValiyariMona SalamiSaeid Bouzari Original Article 26 June 2017 Pages: 451 - 459
Carboplatin plus weekly nanoparticle albumin-bound paclitaxel in elderly patients with previously untreated advanced squamous non-small-cell lung cancer selected based on Mini Nutritional Assessment short-form scores: a multicenter phase 2 study Takayuki ShiroyamaMotohiro TamiyaTakashi Kijima Original Article 07 July 2017 Pages: 461 - 467
Short infusion of paclitaxel imbalances plasmatic lipid metabolism and correlates with cardiac markers of acute damage in patients with breast cancer C. PanisR. BinatoE. Abdelhay Original Article 08 July 2017 Pages: 469 - 478
Impact of an alternative steroid on the relative bioavailability and bioequivalence of a novel versus the originator formulation of abiraterone acetate Azra HussainiAnthony J. OlszanskiPaul Nemeth Original Article Open access 10 July 2017 Pages: 479 - 486
Risk of venous and arterial thromboembolic events associated with VEGFR-TKIs: a meta-analysis Bo LiuFengxia DingGuang-hui Wei Original Article 10 July 2017 Pages: 487 - 495
A phase II trial of erlotinib monotherapy in advanced pancreatic cancer as a first- or second-line agent Christos FountzilasRavi ChhatralaRenuka Iyer Original Article 12 July 2017 Pages: 497 - 505
Sunitinib is effective and tolerable in Chinese patients with advanced pancreatic neuroendocrine tumors: a multicenter retrospective study in China Yuhong WangKaizhou JinJie Chen Original Article 13 July 2017 Pages: 507 - 516
Doxycycline and its quaternary ammonium derivative for adjuvant therapies of chondrosarcoma Imen MiladiMagali VivierElisabeth Miot-Noirault Original Article 13 July 2017 Pages: 517 - 526
Clarithromycin co-administration does not increase irinotecan (CPT-11) toxicity in colorectal cancer patients Katsuya MakiharaSayaka NakamuraIzumi Nakata Original Article 15 July 2017 Pages: 527 - 533
Pharmacokinetics of intravenous pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor [14C]copanlisib (BAY 80-6946) in a mass balance study in healthy male volunteers Michael GerischThomas SchwarzCamille Granvil Original Article Open access 11 July 2017 Pages: 535 - 544
Case series on the association between blood levels and side effects of afatinib maleate Junya SatoNaoto MorikawaKenzo Kudo Original Article 17 July 2017 Pages: 545 - 553
Psoas muscle volume as a predictor of peripheral neurotoxicity induced by primary chemotherapy in ovarian cancers Tomoyuki YoshikawaMasashi TakanoKenichi Furuya Original Article 19 July 2017 Pages: 555 - 561
A phase I study to investigate the metabolism, excretion, and pharmacokinetics of [14C]fruquintinib, a novel oral selective VEGFR inhibitor, in healthy Chinese male volunteers Sufeng ZhouFeng ShaoNing Ou Original Article 20 July 2017 Pages: 563 - 573
Efficacy and safety of taxane monotherapy in advanced gastric cancer refractory to triplet chemotherapy with docetaxel, cisplatin, and S-1: a multicenter retrospective study Sakura IizumiAtsuo TakashimaNarikazu Boku Original Article 20 July 2017 Pages: 575 - 582
Clinical predictors of survival in patients with castration-resistant prostate cancer receiving sipuleucel-T cellular immunotherapy Mehmet Asim BilenKenneth R. HessShi-Ming Tu Original Article 20 July 2017 Pages: 583 - 589
Comparison of RECIST to immune-related response criteria in patients with non-small cell lung cancer treated with immune-checkpoint inhibitors Hee Kyung KimMi Hwa HeoMyung-Ju Ahn Original Article 21 July 2017 Pages: 591 - 598
Exposure–response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial Allen Lee CohnTakayuki YoshinoJosep Tabernero Original Article Open access 25 July 2017 Pages: 599 - 608
Survival data for postoperative adjuvant chemotherapy comprising cisplatin plus vinorelbine after complete resection of non-small cell lung cancer Hirotsugu KenmotsuYasuhisa OhdeToshiaki Takahashi Original Article 31 July 2017 Pages: 609 - 614
A retrospective study of amrubicin monotherapy for the treatment of relapsed small cell lung cancer in elderly patients Hisao ImaiTomohide SugiyamaGunma-Ibaraki-Fukushima-Tochigi (GIFT) group Original Article Open access 31 July 2017 Pages: 615 - 622
Concurrent paclitaxel, capecitabine, mitomycin C and pelvic radiation therapy for patients with squamous cell anal carcinoma Sergey S. GordeyevArsen O. RasulovYulia E. Surayeva Original Article 01 August 2017 Pages: 623 - 629
Phase I study of veliparib in combination with gemcitabine Ronald StollerJohn C. SchmitzJan H. Beumer Original Article 02 August 2017 Pages: 631 - 643
A phase I/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWS–FLI1 fusion transcript Patrick J. GroharJohn GlodBrigitte C. Widemann Clinical Trial Report 22 July 2017 Pages: 645 - 652
Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer Litaty C. MbatchiMatthieu GassiotNadine Houede Short Communication 04 July 2017 Pages: 653 - 659